Project Identifier: LBNL-90-107-H02
Project Title:
Weight Set Point and HDL Levels in Long-Distance Runners (see LBL-93-5-55 in 1994 database)
Principle Investigator:
Dr. Paul T. Williams
Project started in: 1990
Project Funding Information:
Project received funding in Fiscal Year 1995.
Project used human subjects in Fiscal Year 1995.
Funding Sources:
Assignment number: HL-45652
Project does not involve use of multiple protocols/subprojects.
IRB Review:
Type of Review: Full Board
Most Recent Approval: June 09, 1995
IRB Approval Number: 95-6-107
Number of Human Subjects in the Last Reporting Period for this Project: 250
(Reporting periods vary.)
Type of Human Subjects Involvement:
Heparin is administered according to the standard medical procedure for a lipase activity test.
The investigator proposes to examine the difference(s) in diet and lipoprotein metabolism in previously overweight or naturally lean men and women who run or live sedentary lifestyles. The goal is to better understand the relationship between lipoprotein metabolism and weight set-point.
Responses to a survey and analysis of diet records will be correlated with the results of clinical blood testing. Laboratory tests will include standard lipoprotein and cholesterol screening, including for some subjects a separately approved post-heparin lipase activity test.
The risks involved are those common to routine clinical venipuncture (bruising, slight chance of infection) and to the clinical use of the post-heparin lipase activity test (same as venipuncture; very rarely, allergic reaction).